KIMBERLY PARKER: Open Payments
NPI 1215935036 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 31 payments from 17 companies in 2025. Trend: 2023 $673 · 2024 $638 · 2025 $963
Food & beverage: $963
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 5 | $190 |
| Janssen Scientific Affairs, LLC | 1 | $158 |
| Janssen Biotech, Inc. | 3 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $87 |
| Sumitomo Pharma America, Inc. | 3 | $81 |
| Astellas Pharma US Inc | 2 | $56 |
| Dendreon Pharmaceuticals LLC | 2 | $54 |
| Myriad Genetic Laboratories, Inc. | 2 | $40 |
| Verity Pharmaceuticals Inc. | 2 | $29 |
| ABBVIE INC. | 1 | $27 |
Products named: ERLEADA, ADSTILADRIN, Nubeqa, Xtandi, PROVENGE, ORGOVYX, GEMTESA, Trelstar.
Industry payments across GA — which companies pay providers there.
